Monthly Archives: May 2014

Biothera to Present Predictive Biomarker Data at ASCO for Cancer Immunotherapy Imprime PGG

Biothera to Present Predictive Biomarker Data at ASCO for Cancer Immunotherapy Imprime PGG

EAGAN, MN — May 30, 2014 — Biothera will present research at the American Society of Clinical Oncology (ASCO) annual meeting linking a potential predictive serum biomarker to the clinical response to Imprime PGG® immunotherapy in a recent phase 2 study in non-small cell lung cancer patients. The meeting begins today and runs through June 3 in Chicago. Biothera’s Imprime PGG is a yeast-derived, soluble...

Read More